Mankind Pharma Limited has informed the Exchange regarding a press release dated March 18, 2026, titled "Mankind Pharma acquires Rivotril brand for India, reinforcing focus on chronic CNS therapies".
Press Release Mar 18 2026
Earlier from Mankind Pharma
- Press Release Feb 03 2026
- Actimed Therapeutics Announces Important Licensing Agreement with Mankind Pharma
- Press Release Nov 06 2025
- Press Release Jul 31 2025